Thursday, June 1, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

PHEMCE Medical Countermeasure Stakeholders Workshop

by Global Biodefense Staff
November 19, 2015
PHEMC Medical Countermeasures Workshop

U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response will host a Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholder’s Workshop Jan. 6-7, 2016, in Bethesda, Maryland.

This two-day workshop will highlight past progress and future directions in developing, stockpiling and effectively utilizing the drugs, vaccines, and devices that may be required in public health emergencies caused by either naturally occurring epidemics or intentional chemical, biological, radiological and nuclear (CBRN) attacks.

The workshop will feature a mix of plenary sessions and in-depth breakout sessions along four tracks, addressing topics which include:

  • Clinical Guidance on the Use of Medical Countermeasures
  • Biosafety and Biosecurity
  • Post-Marketing Data On Safety and Efficacy for MCMs Approved Under Animal Rule
  • The Strategic National Stockpile
  • Science Needs During Crisis Response
  • Focusing On Populations with Special Needs
  • Influenza and Respiratory Pathogens Update
  • NIH Support and Services for Medical Countermeasure Development
  • Combating Antibiotic Resistant Bacteria Program
  • Past, Present and Future of the MCM Initiative at FDA
  • The MERS CoV Connection
  • Ebola Response – After Action Report

Advance registration is required for the PHEMCE Stakeholders Workshop. Registration will close on December 11, 2015 or when the event reaches capacity.

Source: PHE.gov, adapted.

Tags: AntimicrobialsAntitoxinsAntiviralsBiosafetyEbolaEmerging ThreatsInfluenzaMERS-CoVPandemicVaccines

Related Posts

Vials of finished vaccines
Funding News

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance
Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics
Industry News

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023
Medical Countermeasures

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC